Standardization of cell analysis methods in clinical cellular therapy programs: A challenge for ISCT

Cytotherapy

Volumn 8, Issue 6, 2006, Pages 528-529

  Gratama, J W ^a   Kvalheim, G ^b   Orfao, A ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANALYTIC METHOD; CD34 SELECTION; CD4+ T LYMPHOCYTE; EDITORIAL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOASSAY; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; T LYMPHOCYTE SUBPOPULATION;

CYTOLOGICAL TECHNIQUES; FLOW CYTOMETRY; GOVERNMENT REGULATION; LABORATORY PERSONNEL; QUALITY CONTROL; SOCIETIES, SCIENTIFIC; UNITED STATES;

EID: 33845287292     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240601056354     Document Type: Editorial

References (3)

1. Brando B, Gatti A, Chianese R, Gratama JW. Twenty years of external quality assurance in clinical cell analysis: A tribute to Jean-Luc D'Hautcourt. Cytometry (in press) [EF1].
2. + stem cell counts by single-platform flow cytometry: The way forward Br J Haematol, 106, pp. 1059-62.
3. Dominici, M and Le Blanc, K and Mueller, I and (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy, 8, pp. 315-17.